MOLINARI, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 731
EU - Europa 271
AS - Asia 80
OC - Oceania 2
AF - Africa 1
Totale 1.085
Nazione #
US - Stati Uniti d'America 730
PL - Polonia 136
CN - Cina 59
UA - Ucraina 42
IT - Italia 31
DE - Germania 27
GB - Regno Unito 18
TR - Turchia 17
FI - Finlandia 10
AU - Australia 2
BE - Belgio 2
SE - Svezia 2
VN - Vietnam 2
CA - Canada 1
ES - Italia 1
ID - Indonesia 1
IN - India 1
KE - Kenya 1
NO - Norvegia 1
SI - Slovenia 1
Totale 1.085
Città #
Warsaw 136
Fairfield 103
Woodbridge 83
Houston 71
Chandler 68
Ann Arbor 61
Ashburn 61
Jacksonville 48
Seattle 42
Wilmington 42
Cambridge 32
Beijing 19
Ferrara 11
Nanjing 11
Izmir 10
Princeton 10
Bremen 9
Shanghai 9
Boardman 8
New York 8
San Diego 6
Bologna 4
Cagliari 4
Milan 4
Tianjin 4
Auburn Hills 3
Hebei 3
Norwalk 3
Addison 2
Boston 2
Brussels 2
Changsha 2
Dearborn 2
Dong Ket 2
Ferrara di Monte Baldo 2
Helsinki 2
Jiaxing 2
Kunming 2
Los Angeles 2
Bentleigh East 1
Bonn 1
Caserta 1
Falls Church 1
Granarolo 1
Guangzhou 1
Hangzhou 1
Hounslow 1
Indiana 1
Jinan 1
Las Vegas 1
London 1
Mountain View 1
Nanchang 1
Ningbo 1
Portici 1
Prescot 1
Redwood City 1
San Francisco 1
San Mateo 1
Santa Clara 1
Shenyang 1
Tappahannock 1
Toronto 1
Washington 1
Zhengzhou 1
Totale 921
Nome #
Nociceptin/orphanin FQ – NOP receptor system: novel genetic and pharmacological tools 182
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ. 153
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 125
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111 120
Nociceptin/orphanin FQ receptor knockout rats: in vitro and in vivo studies. 106
In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant 106
In vitro and in vivo pharmacological characterization of the novel NK(1) receptor selective antagonist Netupitant. 100
Pharmacological characterization of the bifunctional opioid ligand H-Dmt-Tic-Gly-NH-Bzl (UFP-505). 96
null 94
Pharmacological profile and antiparkinsonian properties of the novel nociceptin/orphanin FQ receptor antagonist 1-[1-Cyclooctylmethyl-5-(1-hydroxy-1-methyl-ethyl)-1,2,3,6-tetrahydro-pyridin-4-yl]-3-ethyl-1,3-dihydro-benzoimidazol-2-one (GF-4). 22
Totale 1.104
Categoria #
all - tutte 3.494
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.494


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201997 0 0 0 0 0 0 0 0 0 0 40 57
2019/2020286 37 15 11 40 20 28 31 27 24 28 15 10
2020/2021169 14 17 10 20 7 16 18 15 9 18 16 9
2021/2022104 7 16 14 1 0 3 4 5 1 19 12 22
2022/2023136 11 9 8 18 23 16 6 22 18 0 4 1
2023/202462 3 7 3 1 8 14 2 22 2 0 0 0
Totale 1.104